| scholarly article | Q13442814 |
| P50 | author | Callum N Watson | Q61163291 |
| P2093 | author name string | Antonio Belli | |
| Valentina Di Pietro | |||
| P2860 | cites work | Non-coding RNA: what is functional and what is junk? | Q21129493 |
| Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs | Q22121992 | ||
| Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function | Q24295194 | ||
| CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration | Q24295268 | ||
| Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice | Q24603933 | ||
| The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing | Q24628997 | ||
| The piRNA Pathway Guards the Germline Genome Against Transposable Elements | Q26776405 | ||
| Molecular diagnostics of neurodegenerative disorders | Q26786821 | ||
| Untangling the web: the diverse functions of the PIWI/piRNA pathway | Q26851359 | ||
| MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis | Q27321524 | ||
| A blood based 12-miRNA signature of Alzheimer disease patients | Q27499741 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| The spliceosome: design principles of a dynamic RNP machine | Q28131809 | ||
| The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease | Q28305485 | ||
| rRNA modifications and ribosome function | Q28610126 | ||
| TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. | Q38326803 | ||
| The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review. | Q38582520 | ||
| Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients | Q38725663 | ||
| Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis. | Q38765276 | ||
| Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins | Q38789192 | ||
| Altered expression of histamine signaling genes in autism spectrum disorder | Q38796181 | ||
| Early nutrition, epigenetics, and cardiovascular disease | Q38834078 | ||
| Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility? | Q38879200 | ||
| Assembly and trafficking of box C/D and H/ACA snoRNPs | Q38974934 | ||
| Transcriptional regulation of snRNAs and its significance for plant development | Q39024162 | ||
| Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers | Q39134104 | ||
| Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease | Q39227299 | ||
| MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. | Q39476735 | ||
| MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function | Q39545068 | ||
| Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease | Q39573183 | ||
| Global Mapping of Human RNA-RNA Interactions | Q39762850 | ||
| Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
| Genome-wide significant, replicated and functional risk variants for Alzheimer's disease. | Q40096936 | ||
| Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. | Q40231224 | ||
| tRNA N6-adenosine threonylcarbamoyltransferase defect due to KAE1/TCS3 (OSGEP) mutation manifest by neurodegeneration and renal tubulopathy | Q40303611 | ||
| Serum microRNAs in sporadic amyotrophic lateral sclerosis. | Q40769475 | ||
| The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease | Q41037858 | ||
| Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. | Q41570724 | ||
| Detection of stably expressed piRNAs in human blood | Q41962210 | ||
| Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease | Q42839842 | ||
| Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. | Q43143033 | ||
| Early detection of neurodegenerative diseases: circulating brain-enriched microRNA. | Q43249207 | ||
| PRPF4 mutations cause autosomal dominant retinitis pigmentosa | Q43422368 | ||
| Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease | Q43883164 | ||
| Plasma-based circulating MicroRNA biomarkers for Parkinson's disease | Q44075654 | ||
| Circulating miRNAs as potential biomarkers in Alzheimer's disease | Q44261737 | ||
| Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases | Q45325968 | ||
| Circulating miR-125b as a biomarker of Alzheimer's disease. | Q45898313 | ||
| Control of motoneuron survival by angiogenin. | Q46182985 | ||
| Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III. | Q46340186 | ||
| Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer's disease | Q47446093 | ||
| A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease | Q47596091 | ||
| Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment. | Q47755440 | ||
| MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease | Q47767334 | ||
| Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease | Q48000762 | ||
| Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus | Q48266570 | ||
| MicroRNAs as Novel Biomarkers for the Diagnosis and Prognosis of Mild and Severe Traumatic Brain Injury | Q48270947 | ||
| Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia | Q48424286 | ||
| MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects. | Q48496276 | ||
| An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. | Q48502415 | ||
| Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. | Q48505093 | ||
| Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease. | Q48545514 | ||
| miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. | Q48600153 | ||
| MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study | Q49186119 | ||
| Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis | Q49836281 | ||
| Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus. | Q50218454 | ||
| Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease. | Q37507550 | ||
| Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma | Q37549962 | ||
| Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease | Q37615645 | ||
| MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma | Q37669025 | ||
| Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma | Q37688115 | ||
| Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects | Q37725397 | ||
| The role of small nucleolar ribonucleoproteins in ribosome synthesis | Q37854925 | ||
| Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis | Q37970653 | ||
| Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. | Q38194712 | ||
| Circulating miRNAs as biomarkers for neurodegenerative disorders. | Q38214427 | ||
| Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing | Q38244104 | ||
| Emerging roles of tRNA in adaptive translation, signalling dynamics and disease | Q38298151 | ||
| Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state | Q29544165 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Transcriptomic analysis of autistic brain reveals convergent molecular pathology | Q29614877 | ||
| tRFdb: a database for transfer RNA fragments | Q30301351 | ||
| Specific Regional and Age-Related Small Noncoding RNA Expression Patterns Within Superior Temporal Gyrus of Typical Human Brains Are Less Distinct in Autism Brains | Q30396876 | ||
| A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). | Q30436133 | ||
| Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease? | Q30858994 | ||
| MicroRNA expression in Alzheimer blood mononuclear cells | Q30912577 | ||
| Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease? | Q31120249 | ||
| Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs | Q33300324 | ||
| Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology | Q33567669 | ||
| Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3' trailers | Q33586217 | ||
| U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21. | Q33616573 | ||
| The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. | Q33722837 | ||
| Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy. | Q33732095 | ||
| Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). | Q33755664 | ||
| Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease. | Q33894846 | ||
| Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease | Q33905821 | ||
| Emerging role of angiogenin in stress response and cell survival under adverse conditions | Q34029129 | ||
| Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease | Q34049272 | ||
| Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies | Q34144442 | ||
| Mutation of a U2 snRNA gene causes global disruption of alternative splicing and neurodegeneration | Q34248744 | ||
| Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome | Q34274157 | ||
| Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders | Q34332444 | ||
| Slicing tRNAs to boost functional ncRNA diversity | Q34392905 | ||
| Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement | Q34475743 | ||
| Modification of U6 spliceosomal RNA is guided by other small RNAs | Q34482644 | ||
| Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases | Q34547209 | ||
| Circulating miRNA biomarkers for Alzheimer's disease | Q34904013 | ||
| 3' processing of eukaryotic precursor tRNAs. | Q34972005 | ||
| Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q34988061 | ||
| Systematic classification of non-coding RNAs by epigenomic similarity | Q35051466 | ||
| miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement | Q35147342 | ||
| Widespread expression of piRNA-like molecules in somatic tissues | Q35174748 | ||
| Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples | Q35322482 | ||
| MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease | Q35629123 | ||
| Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease. | Q35675907 | ||
| Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. | Q35742846 | ||
| Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers | Q35795155 | ||
| TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes | Q35807549 | ||
| Biomarkers of neurodegenerative disorders: how good are they? | Q35946030 | ||
| Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease | Q35991723 | ||
| Mutations in NSUN2 cause autosomal-recessive intellectual disability. | Q36036572 | ||
| Novel microRNA discovery using small RNA sequencing in post-mortem human brain. | Q36156835 | ||
| Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. | Q36190713 | ||
| Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis | Q36203497 | ||
| Study of plasma-derived miRNAs mimic differences in Huntington's disease brain | Q36469923 | ||
| microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF) | Q36499038 | ||
| MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. | Q36525872 | ||
| SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent. | Q36527783 | ||
| Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease | Q36545671 | ||
| Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. | Q36602121 | ||
| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
| microRNA Profiles in Parkinson's Disease Prefrontal Cortex | Q36634755 | ||
| miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. | Q36687147 | ||
| Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. | Q36738118 | ||
| Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing | Q36742729 | ||
| SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing | Q36746476 | ||
| Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes | Q36838683 | ||
| Diverse human extracellular RNAs are widely detected in human plasma. | Q36859266 | ||
| Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. | Q37029659 | ||
| Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants | Q37096949 | ||
| U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease | Q37236333 | ||
| Angiogenin cleaves tRNA and promotes stress-induced translational repression | Q37237900 | ||
| MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons | Q37261417 | ||
| Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. | Q37353218 | ||
| L-dopa therapy for Parkinson's disease: past, present, and future | Q37364829 | ||
| Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis | Q37485809 | ||
| Downregulated serum miR-223 servers as biomarker in Alzheimer's disease. | Q50535417 | ||
| Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. | Q50657685 | ||
| ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. | Q50738205 | ||
| Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. | Q50932808 | ||
| Serum miR-221 serves as a biomarker for Parkinson's disease. | Q51136725 | ||
| A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease. | Q51620455 | ||
| FUS Regulates Activity of MicroRNA-Mediated Gene Silencing. | Q52369373 | ||
| Minor spliceosome and disease. | Q53050973 | ||
| Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. | Q53448282 | ||
| MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. | Q53457447 | ||
| Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. | Q53512219 | ||
| Expression of microRNA‑222 in serum of patients with Alzheimer's disease. | Q54108151 | ||
| Deep brain stimulation in Parkinson's disease. | Q55460614 | ||
| Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs. | Q55717563 | ||
| Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis | Q58698224 | ||
| Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients | Q58740022 | ||
| Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation | Q58801788 | ||
| Neurodegenerative diseases | Q59083185 | ||
| Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients | Q59531635 | ||
| MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis | Q59791047 | ||
| Identification of blood microRNAs associated to Parkinsonĭs disease | Q83372764 | ||
| Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls | Q86512971 | ||
| Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS | Q86748971 | ||
| Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease | Q86847853 | ||
| RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease | Q88867119 | ||
| Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease | Q89048979 | ||
| tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer | Q91180801 | ||
| Systematic Review of miRNA as Biomarkers in Alzheimer's Disease | Q91413749 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 364 | |
| P577 | publication date | 2019-04-26 | |
| P1433 | published in | Frontiers in Genetics | Q2499875 |
| P1476 | title | Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease | |
| P478 | volume | 10 |
| Q92559936 | A microRNA signature of toxic extrasynaptic N-methyl-D-aspartate (NMDA) receptor signaling |
| Q89821608 | Apoptotic functions of microRNAs in pathogenesis, diagnosis, and treatment of endometriosis |
| Q90704363 | Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury |
| Q90352780 | Identification of a robust non-coding RNA signature in diagnosing autism spectrum disorder by cross-validation of microarray data from peripheral blood samples |
| Q90613590 | The 31-nucleotide Y4-RNA fragment in plasma is a potential novel biomarker |
| Q91866937 | Tissue Specific Reference Genes for MicroRNA Expression Analysis in a Mouse Model of Peripheral Nerve Injury |
Search more.